dr. Althea | 345 Relief Cream $0.00
Description

Dr. Althea 345 Relief Cream โ€“ Dejinta & Daryeelka Maqaarka Xasaasiga ah

Sharaxaad:

Dr. Althea 345 Relief Cream waa kareem dejin iyo dawo u ah maqaarka xanaaqsan, casaanka leh/gadgaduudan, ama dhaawacmay. Waxaa si gaar ah loogu talagalay maqaarka xasaasiga ah, iyadoo ay ka kooban tahay 3 nooc oo Centella Asiatica ah, 4 nooc oo dhir dabiici ah, iyo 5 nooc oo peptides ah โ€“ taasoo ka dhigaysa kareem awood leh oo dejinta, bogsashada, iyo dhisidda maqaarka si isku mar ah u qabta.

  • 3x Centella Asiatica Extracts: Waxay si qoto dheer u dejisaa maqaarka, waxayna xoojiyaan bogsashada unugyada.

  • 4x Botanical Extracts (dhiro dabiici ah): Waxay bixiyaan anti-inflammatory & antioxidant, waxayna yareeyaan xanaaqa iyo casaanka.

  • 5x Peptides: Waxay caawiyaan dib u cusboonaysiinta unugyada, dhisidda xayndaabka maqaarka, iyo yareynta calaamadaha gabowga.

Faaโ€™iidooyinka:

  • Dejinta degdegga ah ee maqaarka xanaaqsan ama casaanka leh

  • Hagaajinta caafimaadka iyo muuqaalka maqaarka

  • Xoojinta difaaca dabiiciga ah ee maqaarka (skin barrier)

  • Qoyaan qoto dheer iyo ilaalin maalin iyo habeenba

Ku habboon:

  • Maqaarka xasaasiga ah ama si sahlan u xanaaqa

  • Maqaarka leh cuncun, gubasho ama casaanka degdegga ah

  • Dadka isticmaala alaab retinol ama exfoliants oo u baahan dejin

Sida loo isticmaalo:
Kadib serum ama toner, mari kareemka wejiga iyo qoorta. Si tartiib ah ugu duug illaa uu si fiican u nuugo. Isticmaal subaxdii iyo fiidkii si joogto ah.


Talo daryeel: 345 Relief Cream waa mid aad u jilicsan, taasoo ka dhigeysa mid ku habboon maqaarka xanuunsan, gubtay ama daallan. Waa kareem loogu talagalay xasillinta maqaarka marka uu sida ugu badan u baahan yahay daryeel.

Reviews (0)
Ratings

0.0

0 Product Ratings
5
0
4
0
3
0
2
0
1
0

Review this product

Share your thoughts with other customers

Write a review

Reviews

There are no reviews yet.

More Offers
No more offers for this product!
Store Policies
Inquiries

General Inquiries

There are no inquiries yet.